Header Logo

Connection

Tiangang Li to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Tiangang Li has written about Combined Modality Therapy.
Tiangang Li
Connection Strength
0.169
Combined Modality Therapy
  1. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
    View in: PubMed
    Score: 0.169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.